drugset
drugset / Trial / NCT00100126

APC-231 Once a Day (QD) for 7 Days vs. Penicillin Taken Four Times a Day (QID) in Pediatric Patients With Strep Throat

NCT00100126 ↗

Phase 3 Completed 500 enrolled Advancis Pharmaceutical Corporation
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of APC-231 QD for 7 days in the bacteriological outcome at the Test of Cure Visit.

Timeline

Start
2004-12
Primary completion
—
Completion
2005-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified — —

Indications

pharyngitis